Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators

Haematologica

Volumn 82, Issue 4, 1997, Pages 415-419

  Pagano, Livio ^a   Tacconelli, Evelina ^a   Tumbarello, Mario ^a   Laurenti, Luca ^a   Barbera, Elettra Ortu La ^a   Antinori, Andrea ^a   Caponera, Savina ^a   Cauda, Roberto ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Hematological malignancy; Prognostic indicators; Risk factors

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; COMPARATIVE STUDY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK FACTOR; STAPHYLOCOCCUS EPIDERMIDIS;

ADULT; BACTEREMIA; CASE-CONTROL STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031465476     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hovgaard D, Skinhoj P, Bangsborg J, Brunn B, Hansen MM, Nissen NI. Bacteremia and candidemia in hematological malignancies: clinical findings. Scand J Infect Dis 1988;20;495-501.
2. EORCT International Antimicrobial Therapy Cooperative Group. Gram-positive bacteremia in granulocytopenic cancer patients. Eur J Cancer 1990; 26:569-74.
3. Fredlund H, Bjoreman M, Kjëllander J, Sjöberg L, Bjorne L, Oklin AL. A 10-year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult patients with hematological diseases at a major Swedish hospital. Scand J Infect Dis 1990; 22:381-91.
4. Gunter G, Björkholm M, Bjorklind A, Eugervall P, Stiernstedt G. Septicemia in patients with hematological disorders and neutropenia. Scand J Infect Dis 1991; 23:589-98.
5. Johansson PJ, Sternby E, Ursing B. Septicemia in granulocytopenic patients: a shift in bacterial aetiology. Scand J Infect Dis 1992; 24:357-60.
6. Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with haematological malignancies. Scand J Infect Dis 1994; 26:77-84.
7. Arpi M, Victor MA, Moller JK, et al. Changing aetiology of bacteremia in patients with haematological malignancies in Denmark. Scand J Infect Dis 1994; 26:157-62.
8. Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MR, Wiernik PH. Origin of infection in acute nonlymphocytic leukemia: significance of hospital acquisition of potential pathogens. Ann Intern Med 1972; 77:704-14.
9. Alpern RJ, Dowell VRJ. Clostridium septicum infections and malignancy. JAMA 1969; 209:385-8.
10. Karp JE, Dick JD, Angelopulos C, et al. Empiric use of vancomycin during prolonged treatment induced granulocytopenia. Randomized double-blind, placebo controlled trial in patients with acute leukemia. Am J Med 1986; 81:237-42.
11. Gimema Infection Program. Prevention of bacterial infection in neutropenic patients with hematological malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Ann Intern Med 1991; 115:7-12.
12. Jansen J, Cromer M, Akard L, Black JR, Wheat J, Allen SD. Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora. Am J Med 1994; 96:335-41.
13. Bow EJ, Loewen R, Vaughan D. Reduced requirement for antibiotic therapy targeting gram-negative organisms in febrile, neutropenic patients with cancer who are receiving antibacterial chemoprophylaxis with oral quinolones. Clin Infect Dis 1995; 20:907-12.
14. Devaux Y, Archimbaud E, Guyotat D, et al. Streptococcal bacteremia in neutropenic adult patients. Nouv Rev Fr Hematol 1992; 34:191-5.
15. Bochud FY, Eggiman PH, Calandra TH, Van Melle C, Saghafi L, Francioli P. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994; 18:25-31.
16. Martino P, Manteiga R, Sanchez I, et al. Viridans streptococcal shock syndrome during bone marrow transplantation. Acta Haematol 1995; 94:69-73.
17. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteremia on HIV infection. Nine years' experience in a large Italian University hospital. J Infect 1995; 31:123-31.
18. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis 1994; 26:635-42.
19. Bodey GP. Infection in cancer patients. Am J Med 1986; 81(1A):11-24.
20. Viola MV. Acute leukemia and infection. JAMA 1967; 201:923-6.
21. Viscoli C, Bruzzi P, Castagnola E. Factors associated with bacteremia in febrile, granulocytopenic cancer patients. Eur J Cancer 1994; 30A:430-7.
22. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-40.
23. Winston DJ, Dudnick DV, Chapin M, Ho WG, Gale RP, Martin WJ. Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med 1983; 143:32-6.
24. Wade JC, Schimpff S, Newman K. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982; 97:503-8.